Octagon Therapeutics


Octagon is developing new medicines for autoimmune disease based on selective immunomodulation.

Industries

Employees

11-50

Links


Org chart

Fred Ausubel
Founding CSO
Collapse
Liguo Wu
Vp, Research And Development

Board & advisors

Gregg Silverman
Scientific Advisor
Iain Kilty
Scientific Advisor
Eric Brown
Scientific Advisor


Offices